These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 10862637)

  • 1. Associations between healthy food groups and platelet-activating factor, lipoprotein-associated phospholipase A
    English CJ; Jones M; Lohning AE; Mayr HL; MacLaughlin H; Reidlinger DP
    Eur J Nutr; 2024 Mar; 63(2):445-460. PubMed ID: 38063929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients-The Effect of Disease Duration.
    Ochocińska A; Wysocka-Mincewicz M; Świderska J; Cukrowska B
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Platelets in Diabetic Kidney Disease.
    Rustiasari UJ; Roelofs JJ
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection.
    Dua P; Mishra A; Reeta KH
    Biomark Med; 2022 Jul; 16(10):821-832. PubMed ID: 35694871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between dietary patterns and the novel inflammatory markers platelet-activating factor and lipoprotein-associated phospholipase A2: a systematic review.
    English CJ; Mayr HL; Lohning AE; Reidlinger DP
    Nutr Rev; 2022 May; 80(6):1371-1391. PubMed ID: 34651191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
    Cheng L; Han X; Shi Y
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1276-82. PubMed ID: 19773578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes.
    Nandy D; Asmann YW; Mukhopadhyay D; Basu A
    J Cell Mol Med; 2010 Jun; 14(6B):1396-407. PubMed ID: 19754670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
    Satoh K
    Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet Activating Factor (PAF): A Mediator of Inflammation.
    Upton JEM; Grunebaum E; Sussman G; Vadas P
    Biofactors; 2022 Nov; 48(6):1189-1202. PubMed ID: 36029481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria.
    Cavallo-Perin P; Lupia E; Gruden G; Olivetti C; De Martino A; Cassader M; Furlani D; Servillo L; Quagliuolo L; Iorio E; Boccellino MR; Montrucchio G; Camussi G
    Nephrol Dial Transplant; 2000 Jul; 15(7):994-9. PubMed ID: 10862637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
    Memon RA; Saeed SA; Jabbar A; Jafri A; Gilani AH; Saleem S; Akbani H
    J Pak Med Assoc; 1995 May; 45(5):122-5. PubMed ID: 7563575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor levels and PAF acetylhydrolase activities in patients with primary glomerulonephritis.
    Iatrou C; Moustakas G; Antonopoulou S; Demopoulos CA; Ziroyiannis P
    Nephron; 1996; 72(4):611-6. PubMed ID: 8730430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated platelet-activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy.
    Denizot Y; Aupetit C; Bridoux F; Alphonse JC; Cogné M; Aldigier JC
    Nephrol Dial Transplant; 2000 Sep; 15(9):1344-7. PubMed ID: 10978389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease.
    Goudevenos J; Tselepis AD; Tsoukatos D; Grekas G; Kritikakos J; Sideris D
    Eur Heart J; 1995 Aug; 16(8):1036-43. PubMed ID: 8665964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating plasma platelet activating factor in persistent pulmonary hypertension of the newborn.
    Caplan MS; Hsueh W; Sun XM; Gidding SS; Hageman JR
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1258-62. PubMed ID: 2252241
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.